Christophe D. B.
- Country
- Belgium
- Department
- Department of Endocrinology, Diabetology and Metabolism
Research Overview
- A Phase 4, Randomized, Open-Label, Active-Controlled Study to Investigate the Efficacy and Safety of Switching From Weekly Dulaglutide to Weekly Tirzepatide in Adults With Type 2 Diabetes
- Evaluation of Verapamil Hydrochloride on Beta-Cell Function Preservation in Adults with Newly Diagnosed Type 1 Diabetes Mellitus
Data & Insights
Has run more than one trial at 2 of 31 partner sites.
Specializations
Diabetes Management
This investigator specializes in the treatment of Type 2 Diabetes Mellitus, with particular focus on innovative therapeutic approaches using novel medications.
- Glycemic Control Optimization
- Diabetes Treatment Transitions
- Long-term Disease Management
Their research explores the effectiveness of different treatment regimens for diabetes control and management.
Cardiovascular Health
The investigator conducts research examining the relationship between diabetes and cardiovascular outcomes, focusing on major cardiovascular events in high-risk patients.
- Cardiovascular Risk Assessment
- Prevention of Cardiac Events
- Cardiovascular Safety Studies
Their work includes evaluation of therapeutic interventions for reducing cardiovascular complications in diabetic patients.
Therapeutic Innovation
The investigator evaluates novel therapeutic agents for diabetes treatment, with emphasis on comparing different treatment modalities and their clinical outcomes.
- Treatment Comparison Studies
- Medication Switching Protocols
- Drug Efficacy Assessment
Their research includes evaluation of treatment transitions and optimization of therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.